Results 311 to 320 of about 591,901 (383)

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

See more, do less?-resident-reported training trends in reconstructive urology. [PDF]

Transl Androl Urol
Neuzil K, Wallen E, Potts JR, DeWitt-Foy ME.   +3 more
europepmc   +1 more source

Empagliflozin after myocardial infarction with or without diabetes and chronic kidney disease: Insights from EMPACT‐MI

ESC Heart Failure, EarlyView.
Impact of empagliflozin in patients with and without T2D or CKD in the EMPACT‐MI trial. Baseline characteristics, HF outcomes and subgroup analysis of efficacy endpoints are shown. # Hazard ratios estimated via Cox proportional hazard model (unless indicated otherwise). ^ Rate ratios via negative binomial regression.
Francesco Fioretti, Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington, Michaela Mattheus, Johann Bauersachs, Antoni Bayes‐Genis, Shaun G. Goodman, Tomasz Gasior, James L. Januzzi, Renato D. Lopes, Piotr Ponikowski, Xavier Rossello, Morten Schou, Peter van der Meer, Dragos Vinereanu, Shelley Zieroth, Martina Brueckmann, Mikhail Sumin, Deepak L. Bhatt, Adrian F. Hernandez, Stefan D. Anker   +23 more
wiley   +1 more source

Transforming Annual Program Evaluation Reviews: AI-Driven Efficiency and Consistency at a Large Institution. [PDF]

J Grad Med Educ
Frederiksen O, Duman H.
europepmc   +1 more source

Galectin‐3 and kidney function in type 2 diabetes treated with dapagliflozin: Analysis from DECLARE‐TIMI 58

ESC Heart Failure, EarlyView.
Abstract Background Galectin‐3 (Gal‐3) is a circulating biomarker of fibrosis, with higher levels being associated with an increased risk of progression of heart failure and kidney disease. Patients with type 2 diabetes mellitus (T2DM) are at increased risk of both.
Paul M. Haller, Stephen D. Wiviott, David D. Berg, Petr Jarolim, Erica L. Goodrich, Deepak L. Bhatt, Ingrid Gause‐Nilsson, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Itamar Raz, Marc S. Sabatine, David A. Morrow   +12 more
wiley   +1 more source

Impacts of the Accreditation Process for Undergraduate Medical Schools: A Scoping Review. [PDF]

Clin Teach
Girotto LC, Machado KB, Moreira RFC, Martins MA, Tempski PZ.   +4 more
europepmc   +1 more source

Artificial intelligence fully automated analysis of handheld echocardiography in real‐world patients with suspected heart failure

European Journal of Heart Failure, EarlyView.
Artificial intelligence (AI) reporting of handheld echocardiography in a real‐life cohort of patients with suspected heart failure (HF). COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NTproBNP, N‐terminal pro‐B‐type natriuretic peptide.
Ross T. Campbell, Mark C. Petrie, Kieran F. Docherty, Katriona J.M. Brooksbank, Gemma McKinley, Caroline Haig, Alex McConnachie, Carolyn S.P. Lam, Carly Adamson, Elaine Butler, James P. Curtain, Nick Hartshorne‐Evans, Fraser J. Graham, Helen Hainey, John Jarvie, Matthew M.Y. Lee, Leeanne Macklin, Kenneth Mangion, Aimee McCoubrey, Kirsty McDowell, Aileen McIntyre, Sabrina Nordin, Joanna Osmanska, Pierpaolo Pellicori, Joanne Simpson, Piotr Sonecki, Karen Taylor, Daniel Taylor‐Sweet, Pamela Turnbull, Paul Welsh, John J.V. McMurray, Clare L. Murphy, David J. Lowe   +32 more
wiley   +1 more source

An Ecosystem Approach to Developing and Implementing a Cocreated Bachelor's Degree in Digital Health and Biomedical Innovation.

JMIR Med Educ
Alves P, Costa E, Costa-Pereira A, Falcão-Pires I, Fonseca J, Leite-Moreira A, Sousa-Pinto B, Vale N.   +7 more
europepmc   +1 more source

The Expansion Dilemma: A Critical Look at the 13-Year Increase in Emergency Medicine Residency Positions. [PDF]

AEM Educ Train
Schnabel N, Okoli D, Calabrese J, Davis M, Haas M, Hopson L, Pelletier-Bui A.   +6 more
europepmc   +1 more source

Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC

European Journal of Heart Failure, EarlyView.
Barriers and solutions to referral and therapy implementation in advanced heart failure. EMR, electronic medical record; HF, heart failure; HT, heart transplantation; ICARe‐HF, integrated care for advanced heart failure; LVAD, left ventricular assist device; MCS, mechanical circulatory support; OMT, optimal medical therapy; RCT, randomized controlled ...
Guillaume Baudry, Maria Generosa Crespo‐Leiro, Clément Delmas, Federica Guidetti, Marta Jimenez‐Blanco Bravo, Federica Valente, Maja Cikes, Nicolas Girerd, Finn Gustafsson, Gianluigi Savarese, Linda W. van Laake, Loreena Hill, Anne Kathrine Skibelund, Andreas Zuckermann, Marco Metra, Kevin Damman   +15 more
wiley   +1 more source